Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract Cancer.
Sven Heiko LoosenTom F UlmerSimon LabuhnJan BednarschSven A LangPatrick H AlizaiAnne T SchneiderMihael VucurUlf P NeumannTom LueddeChristoph RoderburgPublished in: Cancers (2022)
Our data support a fundamental role of the CXC chemokine family in BTC and identified circulating levels of CXCL13 as a previously unrecognized marker for predicting outcomes following the resection of BTC.